176 related articles for article (PubMed ID: 15841646)
1. Imiquimod: an effective alternative for the treatment of invasive cutaneous squamous cell carcinoma.
Martín-García RF
Dermatol Surg; 2005 Mar; 31(3):371-4. PubMed ID: 15841646
[TBL] [Abstract][Full Text] [Related]
2. Imiquimod 5% cream in the treatment of Bowen's disease and invasive squamous cell carcinoma.
Peris K; Micantonio T; Fargnoli MC; Lozzi GP; Chimenti S
J Am Acad Dermatol; 2006 Aug; 55(2):324-7. PubMed ID: 16844522
[TBL] [Abstract][Full Text] [Related]
3. Invasive squamous cell carcinoma treated with imiquimod 5% cream.
Flórez A; Feal C; de la Torre C; Cruces M
Acta Derm Venereol; 2004; 84(3):227-8. PubMed ID: 15202841
[No Abstract] [Full Text] [Related]
4. Two cases of squamous cell carcinoma treated with topical imiquimod 5%.
Oster-Schmidt C
J Eur Acad Dermatol Venereol; 2004 Jan; 18(1):93-5. PubMed ID: 14678542
[TBL] [Abstract][Full Text] [Related]
5. Treatment of multiple lesions of Bowen's disease and squamous cell carcinoma with topical imiquimod.
Palungwachira P; Palungwachira P; Ogawa H
J Dermatol; 2005 Dec; 32(12):1005-9. PubMed ID: 16471467
[TBL] [Abstract][Full Text] [Related]
6. Imiquimod - Its role in the treatment of cutaneous malignancies.
Bubna AK
Indian J Pharmacol; 2015; 47(4):354-9. PubMed ID: 26288465
[TBL] [Abstract][Full Text] [Related]
7. Apparent clinical resolution of pinnal actinic keratoses and squamous cell carcinoma in a cat using topical imiquimod 5% cream.
Peters-Kennedy J; Scott DW; Miller WH
J Feline Med Surg; 2008 Dec; 10(6):593-9. PubMed ID: 18417398
[TBL] [Abstract][Full Text] [Related]
8. Treatment of invasive squamous cell carcinoma with 5-percent imiquimod cream.
Konstantopoulou M; Lord MG; Macfarlane AW
Dermatol Online J; 2006 Mar; 12(3):10. PubMed ID: 16638424
[TBL] [Abstract][Full Text] [Related]
9. Clinical and histological resolution of invasive squamous cell carcinoma by topical imiquimod 3.75%: a case report.
Dirschka T; Schmitz L; Bartha Á
Eur J Dermatol; 2016 Aug; 26(4):408-9. PubMed ID: 27097553
[No Abstract] [Full Text] [Related]
10. Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience.
Tillman DK; Carroll MT
Cutis; 2007 Mar; 79(3):241-8. PubMed ID: 17674590
[TBL] [Abstract][Full Text] [Related]
11. [Solar keratosis: from precancerous lesion to pre-invasive squamous cell carcinoma--therapeutic approach with a bioinductive method].
Oster-Schmidt C; Altmeyer P; Markus S
J Dtsch Dermatol Ges; 2003 Oct; 1(10):790-6. PubMed ID: 16281815
[TBL] [Abstract][Full Text] [Related]
12. Multicentre, open-label study using imiquimod 5% cream in one or two 4-week courses of treatment for multiple actinic keratoses on the head.
Stockfleth E; Sterry W; Carey-Yard M; Bichel J
Br J Dermatol; 2007 Dec; 157 Suppl 2():41-6. PubMed ID: 18067631
[TBL] [Abstract][Full Text] [Related]
13. Topical immunomodulation under systemic immunosuppression: results of a multicentre, randomized, placebo-controlled safety and efficacy study of imiquimod 5% cream for the treatment of actinic keratoses in kidney, heart, and liver transplant patients.
Ulrich C; Bichel J; Euvrard S; Guidi B; Proby CM; van de Kerkhof PC; Amerio P; Rønnevig J; Slade HB; Stockfleth E
Br J Dermatol; 2007 Dec; 157 Suppl 2(Suppl 2):25-31. PubMed ID: 18067628
[TBL] [Abstract][Full Text] [Related]
14. Imiquimod for the treatment of Bowen's disease and invasive squamous cell carcinoma.
Nouri K; O'Connell C; Rivas MP
J Drugs Dermatol; 2003 Dec; 2(6):669-73. PubMed ID: 14711149
[TBL] [Abstract][Full Text] [Related]
15. Use of imiquimod 5% cream (Aldara) in cats with multicentric squamous cell carcinoma in situ: 12 cases (2002-2005).
Gill VL; Bergman PJ; Baer KE; Craft D; Leung C
Vet Comp Oncol; 2008 Mar; 6(1):55-64. PubMed ID: 19178663
[TBL] [Abstract][Full Text] [Related]
16. Squamous cell carcinoma in situ of the penis successfully treated with imiquimod 5% cream.
Schroeder TL; Sengelmann RD
J Am Acad Dermatol; 2002 Apr; 46(4):545-8. PubMed ID: 11907505
[TBL] [Abstract][Full Text] [Related]
17. Clearance of basal cell and superficial squamous cell carcinomas after imiquimod therapy.
Warshauer E; Warshauer BL
J Drugs Dermatol; 2008 May; 7(5):447-51. PubMed ID: 18505136
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of persistent melanoma in situ with 5% imiquimod cream.
Muñoz CM; Sánchez JL; Martín-García RF
Dermatol Surg; 2004 Dec; 30(12 Pt 2):1543-5. PubMed ID: 15606836
[TBL] [Abstract][Full Text] [Related]
19. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe.
Schulze HJ; Cribier B; Requena L; Reifenberger J; Ferrándiz C; Garcia Diez A; Tebbs V; McRae S
Br J Dermatol; 2005 May; 152(5):939-47. PubMed ID: 15888150
[TBL] [Abstract][Full Text] [Related]
20. Complete response of locally advanced cutaneous squamous cell carcinoma of the eyelid to topical imiquimod 3.75.
Toso F; Tronconi MC; Cortese A; Fiorillo G; Bressan A; Costanzo A; Borroni RG
Dermatol Ther; 2022 Nov; 35(11):e15800. PubMed ID: 36066074
[No Abstract] [Full Text] [Related]
[Next] [New Search]
